A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome
Xin Jiang,Yushuang Xu,Di Chen,Mengmeng Wang,Mengjun Qiu,Lina Xiong,Li Zhang,Honglu Yu,Zhifan Xiong
DOI: https://doi.org/10.2147/IJGM.S349210
IF: 2.145
2022-01-07
International Journal of General Medicine
Abstract:Xin Jiang, Yushuang Xu, Di Chen, Mengmeng Wang, Mengjun Qiu, Lina Xiong, Li Zhang, Honglu Yu, Zhifan Xiong Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China Correspondence: Zhifan Xiong Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China Tel +86 13517281937 Email Purpose: Hepatocellular carcinoma (HCC) is a highly vascularized solid tumor characterized by neovascularization and vascular invasion. Angiogenesis plays an essential role in the occurrence and development of liver cancer. Our study aimed to investigate the prognostic value of angiogenesis-related genes in liver cancer. Patients and Methods: The transcriptome data and corresponding clinical information of patients with liver cancer were downloaded from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) databases. In the TCGA cohort, differential expression and prognostic analyses were used to screen angiogenesis-related candidate prognostic genes. We then used least absolute shrinkage and selection operator regression analysis to construct a prognostic signature using 10 angiogenesis-related prognostic genes. The reliability of the prognostic signature was assessed in the TCGA and ICGC cohorts. In addition, we comprehensively analyzed the correlation of the prognostic signature with the tumor microenvironment, chemotherapy drugs, and specific genes. Results: We identified 37 angiogenesis-related differentially expressed genes that were remarkably associated with prognosis. Ten of these genes were used to establish a survival and prognostic signature. This signature can distinguish between high-risk and low-risk groups and performs well in overall survival prediction, as demonstrated by internal and external validations. In addition, we observed that the high-risk group was remarkably associated with immune infiltration in the tumor microenvironment and had a different sensitivity to chemotherapeutic agents compared with the low-risk group. Moreover, the high-risk population was positively correlated with the expression of several special genes, such as immune checkpoint-related genes. Conclusion: Our results demonstrated that prognostic signatures based on angiogenesis-related genes are involved in the development of HCC and may provide new insights into accurate clinical decision-making and therapeutic evaluation of patients with HCC. Keywords: hepatocellular carcinoma, angiogenesis-related gene, signature, tumor microenvironment, immune infiltration, prognosis Liver cancer is one of the most common malignancies in the world. This condition has various histological types, among which hepatocellular carcinoma (HCC) accounts for 83%. 1 HCC is a highly complex type of cancer driven by multiple factors, such as hepatitis virus infection, metabolic abnormalities, and liver fibrosis. 2 Liver cancer treatment involves various methods, including chemotherapy, targeted therapy, surgical resection, and liver transplantation. 3 However, only a small number of patients benefit from each method, and the 5-year survival rate of patients with liver cancer is still low. 4 Therefore, understanding the molecular mechanism of HCC development and identifying new biomarkers to predict clinical outcomes and therapeutic targets in patients with HCC are crucial. HCC, as a kind of hypervascular tumor, is the fifth-largest cancer in the world. 5 Angiogenesis plays an essential role in the development of liver cancer. Tumor blood vessels are the main pathways for nutrient exchange and metabolic waste removal in tumors. 6 Angiogenesis plays an essential role in the development of liver cancer. Tumor blood vessels are the main pathways for nutrient exchange and metabolic waste removal in tumors. 7–9 Anti-angiogenic therapy has consistently been the focus of HCC research, and most therapies for advanced HCC target the angiogenic pathway. Sorafenib, a multi-kinase inhibitor that targets vascular endothelial growth factor receptor, remarkably improves the overall survival (OS) of patients with HCC. 10,11 However, most research has focused on the influence of individual genes on prognosis. The construction of multiple angiogenesis-related gene models seems to provide effective risk identification and potential targets for HCC clinical treatment. The emergence of various public databases based on the development of high-throughput technology has provided researchers with great opportunities for statistical analysis. 12,13 The present study used transcriptome -Abstract Truncated-
medicine, general & internal